Having trouble accessing articles? Reset your cache.

Getting to the essence of Staph

Two recent studies from The University of Chicago have identified vaccine candidates to prevent Staphylococcus aureusinfection.1,2 The researchers think their strategy of targeting essential surface-localized virulence factors could generate better results than current vaccination approaches, which have yet to show success in humans.

The hypothesis will now need to be put to the test by subjecting the new vaccines to clinical safety and efficacy trials.

Both studies were led by Olaf Schneewind, professor and chair of the Department of Microbiology, who has been focused on identifying proteins on the S. aureus

Read the full 896 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE